China’s blood product makers face potentially challenging year
HONG KONG – The market for expensive blood products in China is attracting biotech companies looking to boost their bottom lines, but a surge in imports, driven by high supply levels abroad, is pressuring the bottom lines of domestic suppliers.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter